Oculis Holding AG OCS
NASDAQ OCS
$12.17 +0.00 (+0.00%)
At close: Sep 4, 2026 · 4:00 PM EDT

Oculis Holding AG (OCS) Other Non Operating Income (2022 - 2026)

Oculis Holding AG (OCS) posted quarterly Other Non Operating Income of -$5.7 million for Q2 2025, down 1836.74% year-over-year from $329247.1 in Q2 2024, and down 228.08% quarter-over-quarter from -$1.7 million in Q1 2025.

Analysis

Oculis Holding AG (OCS) Other Non Operating Income (2022 - 2026) Analysis & Trends

Oculis Holding AG's Other Non Operating Income history runs 4 years deep, the most recent figure standing at -$5.7 million for Q2 2025.

  • In Q2 2025, Other Non Operating Income fell 1836.74% year-over-year to -$5.7 million; the TTM figure through Jun 2025 stood at -$7.8 million (down 110.77% YoY), while the FY2024 annual figure was $1.4 million, up 127.78% from the prior year.
  • Other Non Operating Income for Q2 2025 stood at -$5.7 million, down from -$1.7 million in the prior quarter.
  • The five-year high for Other Non Operating Income was $3.3 million in Q4 2022, with the low at -$5.7 million in Q2 2025.
  • The 4-year median for Other Non Operating Income is -$1.3 million (2022), against an average of -$829491.5.
  • The sharpest annual moves came in 2024 and 2025: Other Non Operating Income soared 882.33% in 2024, then plunged 1836.74% in 2025.
  • Oculis Holding AG's Other Non Operating Income stood at $3.3 million in 2022, then sank by 174.35% to -$2.5 million in 2023, then jumped by 175.75% to $1.9 million in 2024, then sank by 407.32% to -$5.7 million in 2025.
  • Business Quant data shows OCS's Other Non Operating Income at -$5.7 million in Q2 2025, -$1.7 million in Q1 2025, and $1.9 million in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Oculis Holding AG 634.75 Mn 345.87 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.54 Mn
Mar 31, 2026 724,061.65
Dec 31, 2025 121,363.47
Sep 30, 2025 111,259.75
Jun 30, 2025 -5.72 Mn
Mar 31, 2025 -1.74 Mn
Dec 31, 2024 1.86 Mn
Sep 30, 2024 -2.18 Mn
Jun 30, 2024 -295,246.86
Mar 31, 2024 2.06 Mn
Dec 31, 2023 -2.46 Mn
Sep 30, 2023 -2.99 Mn
Jun 30, 2023 453,767.62
Mar 31, 2023 -262,722.51
Dec 31, 2022 3.30 Mn
Sep 30, 2022 -1.35 Mn
Jun 30, 2022 -1.46 Mn